フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
CHAD Therapeutics, Inc. (AMEX:CTU) announced today that it has commenced mailing its definitive proxy statement to shareholders...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION...
SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ...
OMB APPROVAL OMB Number: 3235-0058 Expires: April 30...
Table of Contents SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES...
CHAD Therapeutics, Inc. (AMEX:CTU) today reported financial results for the first quarter of fiscal 2008. First Quarter...
CHAD Therapeutics, Inc. (AMEX:CTU) today announced the completion of a $3,500,000 financing package with a private investor that...
CHAD Therapeutics, Inc. (AMEX:CTU) today reported financial results for the fourth quarter and fiscal year ended March 31, 2007...
CHAD Therapeutics, Inc. (AMEX:CTU) today announced the launch of an advanced pneumatic oxygen conserver and its next-generation...
CHAD Therapeutics, Inc. (AMEX:CTU) today reported financial results for the second quarter and first half of fiscal 2007...
CHAD Therapeutics, Inc. (AMEX:CTU) today reported financial results for the first quarter of fiscal 2007, and provided an update on the Company's...
CHAD Therapeutics, Inc. (AMEX:CTU) today reported financial results for the fourth quarter and fiscal 2006, and provided an update on the...
CHAD Therapeutics, Inc. (AMEX:CTU) announced today that it has been named the 2006 Frost & Sullivan Product Line Strategy Leadership Award winner...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約